Tetrahydrofuran → 2-[5-(4-Isobutyl-phenyl)-[1,2,4]oxadiazol-3-yl]-pyrimidine-5-carbaldehyde

HRID 2242216Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2242216
C([Li])CCC.Cl[C:7]1[CH:8]=[N:9][C:10]([C:13]2[N:17]=[C:16]([C:18]3[CH:23]=[CH:22][C:21]([CH2:24][CH:25]([CH3:27])[CH3:26])=[CH:20][CH:19]=3)[O:15][N:14]=2)=[N:11][CH:12]=1.C1C[O:31][CH2:30]C1>CN(C=O)C>[CH2:24]([C:21]1[CH:22]=[CH:23][C:18]([C:16]2[O:15][N:14]=[C:13]([C:10]3[N:9]=[CH:8][C:7]([CH:30]=[O:31])=[CH:12][N:11]=3)[N:17]=2)=[CH:19][CH:20]=1)[CH:25]([CH3:27])[CH3:26]

Komponenten

5

Reaktionsbedingungen

Temperatur
0 °C

Versuchsvorschrift

n-Butyllithium (4.77 mL, 7.16 mmol) was added to a solution of 5-chloro-2-[5-(4-isobutyl-phenyl)-[1,2,4]oxadiazol-3-yl]-pyrimidine (1.5 g, 4.77 mmol) and THF (50 mL) at −78° C. and stirred for 7 hours DMF (3 mL) was added to the reaction mixture, warmed to 0° C. and stirred for 2 hours. The reaction mixture was quenched with saturated aqueous ammonium chloride (15 mL) and stirred at room temperature for 12 hours. The reaction mixture was diluted with EtOAc (25 mL) and the organic layer was separated and washed with water (3×25 mL) and brine (1×25 mL) and concentrated in vacuo to provide the title compound (1.13 g, 76% yield) as an orange solid.

Aufarbeitung

  1. additionwas added to the reaction mixture
  2. customThe reaction mixture was quenched with saturated aqueous ammonium chloride (15 mL)
  3. stirringstirred at room temperature for 12 hours
  4. additionThe reaction mixture was diluted with EtOAc (25 mL)
  5. customthe organic layer was separated
  6. washwashed with water (3×25 mL) and brine (1×25 mL)
  7. concentrationconcentrated in vacuo

Quellen und Nachweise

ORD-Eintrag
ord-de8ab14b3d924962abfc769dbb8f72f4
Quelldatensatz
uspto-grants-2010_03
Patentnummer
US07671043B2

Notizen zur Reaktion

Wird geladen…